Liposome encapsulated daunorubicin (daunoxome) for acute leukemia

Authors
Ermacora, A Michieli, M Pea, F Visani, G Bucalossi, A Russo, D
Citation
A. Ermacora et al., Liposome encapsulated daunorubicin (daunoxome) for acute leukemia, HAEMATOLOG, 85(3), 2000, pp. 324-325
Citations number
6
Categorie Soggetti
Cardiovascular & Hematology Research
Journal title
HAEMATOLOGICA
ISSN journal
03906078 → ACNP
Volume
85
Issue
3
Year of publication
2000
Pages
324 - 325
Database
ISI
SICI code
0390-6078(200003)85:3<324:LED(FA>2.0.ZU;2-B
Abstract
Daunoxome (DNX, Nexstar) was given, as a single agent, to 11 patients with very poor-risk acute leukemia. Pharmacokinetic data were also obtained from 9 of the 11 cases. This small pilot study show that the toxic profile of t his liposomal-encapsulated anthracycline is low.